Cargando…

Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development

Contact with many different biological membranes goes along the destiny of a drug after its systemic administration. From the circulating macrophage cells to the vessel endothelium, to more complex absorption barriers, the interaction of a biomolecule with these membranes largely affects its rate an...

Descripción completa

Detalles Bibliográficos
Autores principales: Pignatello, R., Musumeci, T., Basile, L., Carbone, C., Puglisi, G.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053521/
https://www.ncbi.nlm.nih.gov/pubmed/21430952
http://dx.doi.org/10.4103/0975-7406.76461
_version_ 1782199758301954048
author Pignatello, R.
Musumeci, T.
Basile, L.
Carbone, C.
Puglisi, G.
author_facet Pignatello, R.
Musumeci, T.
Basile, L.
Carbone, C.
Puglisi, G.
author_sort Pignatello, R.
collection PubMed
description Contact with many different biological membranes goes along the destiny of a drug after its systemic administration. From the circulating macrophage cells to the vessel endothelium, to more complex absorption barriers, the interaction of a biomolecule with these membranes largely affects its rate and time of biodistribution in the body and at the target sites. Therefore, investigating the phenomena occurring on the cell membranes, as well as their different interaction with drugs in the physiological or pathological conditions, is important to exploit the molecular basis of many diseases and to identify new potential therapeutic strategies. Of course, the complexity of the structure and functions of biological and cell membranes, has pushed researchers toward the proposition and validation of simpler two- and three-dimensional membrane models, whose utility and drawbacks will be discussed. This review also describes the analytical methods used to look at the interactions among bioactive compounds with biological membrane models, with a particular accent on the calorimetric techniques. These studies can be considered as a powerful tool for medicinal chemistry and pharmaceutical technology, in the steps of designing new drugs and optimizing the activity and safety profile of compounds already used in the therapy.
format Text
id pubmed-3053521
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30535212011-03-22 Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development Pignatello, R. Musumeci, T. Basile, L. Carbone, C. Puglisi, G. J Pharm Bioallied Sci Symposium Contact with many different biological membranes goes along the destiny of a drug after its systemic administration. From the circulating macrophage cells to the vessel endothelium, to more complex absorption barriers, the interaction of a biomolecule with these membranes largely affects its rate and time of biodistribution in the body and at the target sites. Therefore, investigating the phenomena occurring on the cell membranes, as well as their different interaction with drugs in the physiological or pathological conditions, is important to exploit the molecular basis of many diseases and to identify new potential therapeutic strategies. Of course, the complexity of the structure and functions of biological and cell membranes, has pushed researchers toward the proposition and validation of simpler two- and three-dimensional membrane models, whose utility and drawbacks will be discussed. This review also describes the analytical methods used to look at the interactions among bioactive compounds with biological membrane models, with a particular accent on the calorimetric techniques. These studies can be considered as a powerful tool for medicinal chemistry and pharmaceutical technology, in the steps of designing new drugs and optimizing the activity and safety profile of compounds already used in the therapy. Medknow Publications 2011 /pmc/articles/PMC3053521/ /pubmed/21430952 http://dx.doi.org/10.4103/0975-7406.76461 Text en © Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium
Pignatello, R.
Musumeci, T.
Basile, L.
Carbone, C.
Puglisi, G.
Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development
title Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development
title_full Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development
title_fullStr Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development
title_full_unstemmed Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development
title_short Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development
title_sort biomembrane models and drug-biomembrane interaction studies: involvement in drug design and development
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053521/
https://www.ncbi.nlm.nih.gov/pubmed/21430952
http://dx.doi.org/10.4103/0975-7406.76461
work_keys_str_mv AT pignatellor biomembranemodelsanddrugbiomembraneinteractionstudiesinvolvementindrugdesignanddevelopment
AT musumecit biomembranemodelsanddrugbiomembraneinteractionstudiesinvolvementindrugdesignanddevelopment
AT basilel biomembranemodelsanddrugbiomembraneinteractionstudiesinvolvementindrugdesignanddevelopment
AT carbonec biomembranemodelsanddrugbiomembraneinteractionstudiesinvolvementindrugdesignanddevelopment
AT puglisig biomembranemodelsanddrugbiomembraneinteractionstudiesinvolvementindrugdesignanddevelopment